← Open Payments lookup

CAROL WAMBOLDT: Open Payments

NPI 1316975048 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,531 in 84 payments from 16 companies in 2025. Trend: 2023 $856 · 2024 $1,267 · 2025 $1,531

Food & beverage: $1,531
CompanyPaymentsAmount
ABBVIE INC.50$664
Eisai Inc.4$134
Lundbeck LLC5$129
EMD Serono, Inc.4$91
Teva Pharmaceuticals USA, Inc.3$86
Neurelis, Inc.4$84
Alnylam Pharmaceuticals Inc.2$61
TG Therapeutics, Inc.2$43
Lilly USA, LLC2$41
Otsuka America Pharmaceutical, Inc.2$37

Products named: QULIPTA, Leqembi, BOTOX, VYEPTI, UBRELVY, AJOVY, VALTOCO, AMVUTTRA.

Industry payments across MD — which companies pay providers there.